Pages that link to "Q41753654"

The following pages link to Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth (Q41753654):

Displaying 46 items.

• Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study (Q21245275) (← links)
• Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts (Q28211600) (← links)
• Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions (Q28361966) (← links)
• Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (Q34115984) (← links)
• Risk of cancer in a large cohort of U.S. veterans with diabetes. (Q34234264) (← links)
• Diabetes and pancreatic cancer (Q34634263) (← links)
• A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression (Q34943133) (← links)
• Mechanisms of obesity-induced gastrointestinal neoplasia (Q35062195) (← links)
• Insulin-like growth factor expression in breast cancer epithelium and stroma (Q35465049) (← links)
• Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. (Q35625849) (← links)
• Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer (Q35791879) (← links)
• Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor (Q35816926) (← links)
• Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (Q35835118) (← links)
• Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha (Q35993625) (← links)
• Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer? (Q36540064) (← links)
• Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts (Q36614961) (← links)
• Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver (Q36659097) (← links)
• Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study (Q36746724) (← links)
• Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer (Q37010354) (← links)
• Metabolism addiction in pancreatic cancer (Q37620679) (← links)
• Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta (Q39887874) (← links)
• Adhesion molecules and their role in cancer metastasis. (Q40615153) (← links)
• Hormonal therapy of pancreatic carcinoma. Rationale and perspectives. (Q40712629) (← links)
• Transforming growth factor alpha (TGF-alpha) increases cell number in a human pancreatic cancer cell line but not in normal mouse pancreas (Q40803514) (← links)
• The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis (Q40855140) (← links)
• The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I. (Q40994708) (← links)
• Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes (Q41177023) (← links)
• HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line (Q41481739) (← links)
• Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors (Q41510756) (← links)
• Human pancreatic cancer cell lines do not express receptors for somatostatin (Q41606257) (← links)
• Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro-cAMP in vitro (Q41836390) (← links)
• Pancreatic Cancer Heralded by Worsening Glycemic Control: A Report of Two Cases. (Q42206180) (← links)
• Molecular differences between human and experimental pancreaticobiliary diversion-induced rat pancreatic neoplasia (Q43220291) (← links)
• Growth factors and pancreatic cancer (Q44450443) (← links)
• Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression (Q46973426) (← links)
• Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma (Q47375627) (← links)
• Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer (Q50314975) (← links)
• Diabetes Type 2 and Pancreatic Cancer: A History Unfolding. (Q55340463) (← links)
• Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines (Q64038852) (← links)
• Insulin-like growth factors and cancer (Q67487325) (← links)
• Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors (Q71689665) (← links)
• Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer (Q73916862) (← links)
• Immunodetection of Insulin-Like Growth Factor I (IGF-l) in Normal and Pathological Adrenocortical Tissue (Q74453743) (← links)
• Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma (Q77750257) (← links)
• Measurement of pS2 protein in pancreatic cyst fluids. Evidence for a potential role of pS2 protein in the pathogenesis of mucinous cystic tumors (Q77750261) (← links)
• Downregulation of the let-7 family of microRNAs may promote insulin receptor/insulin-like growth factor signalling pathways in pancreatic ductal adenocarcinoma (Q98386387) (← links)